Description
Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist designed to help improve blood sugar control in adults with type 2 diabetes. It is administered as a once-weekly subcutaneous injection and has also been studied for weight management benefits.
•Form: Prefilled injection pen
•Use: Weekly subcutaneous injection
•Note: Prescription required.
Reviews
There are no reviews yet.